Middlemen net more than half of insulin expenditures, USC Schaeffer study finds
Despite being discovered nearly 100 years ago, insulin’s list price has been going up, not down, with trade secrets and other protections preventing researchers from pinpointing who is receiving profits from its sale. Meanwhile, the net price — what manufacturers … Read More »